|
1
|
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
|
Am J Gastroenterol
|
2008
|
2.16
|
|
2
|
AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.
|
Gastroenterology
|
2010
|
2.09
|
|
3
|
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
|
Am J Gastroenterol
|
2011
|
2.04
|
|
4
|
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
|
Gut
|
2011
|
1.70
|
|
5
|
An evidence-based systematic review on medical therapies for inflammatory bowel disease.
|
Am J Gastroenterol
|
2011
|
1.42
|
|
6
|
The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis.
|
J Clin Gastroenterol
|
2012
|
1.38
|
|
7
|
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
|
Inflamm Bowel Dis
|
2013
|
1.33
|
|
8
|
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
|
Am J Gastroenterol
|
2011
|
1.24
|
|
9
|
Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population.
|
Clin Gastroenterol Hepatol
|
2012
|
1.23
|
|
10
|
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2007
|
1.14
|
|
11
|
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.
|
Inflamm Bowel Dis
|
2008
|
1.09
|
|
12
|
Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence.
|
Inflamm Bowel Dis
|
2011
|
0.97
|
|
13
|
A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
|
J Clin Gastroenterol
|
2013
|
0.96
|
|
14
|
Current practice and perception of screening for medication adherence in inflammatory bowel disease.
|
J Clin Gastroenterol
|
2011
|
0.96
|
|
15
|
Improving quality of care in IBD: a STEEEP challenge.
|
Inflamm Bowel Dis
|
2010
|
0.90
|
|
16
|
Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
|
J Crohns Colitis
|
2013
|
0.86
|
|
17
|
Chemoprevention of colorectal cancer in ulcerative colitis.
|
Int J Colorectal Dis
|
2003
|
0.85
|
|
18
|
Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis.
|
Dis Colon Rectum
|
2009
|
0.85
|
|
19
|
Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors.
|
Scand J Gastroenterol
|
2015
|
0.84
|
|
20
|
The management of immunosuppression in patients with inflammatory bowel disease and cancer.
|
Gut
|
2013
|
0.83
|
|
21
|
Inflammatory bowel disease-associated cancers: does gender change incidence?
|
Gastroenterology
|
2010
|
0.79
|
|
22
|
Gut microbes in Crohn's disease: getting to know you better?
|
Am J Gastroenterol
|
2008
|
0.76
|
|
23
|
The certain uncertainty of measuring disease activity in IBD.
|
J Clin Gastroenterol
|
2007
|
0.75
|
|
24
|
The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD.
|
Am J Gastroenterol
|
2012
|
0.75
|
|
25
|
Looking forward to understanding and reducing colorectal cancer risk in inflammatory bowel disease.
|
Gastroenterology
|
2013
|
0.75
|
|
26
|
Tacrolimus for active ulcerative colitis? Yes! (Even though Cochrane says "no").
|
Gastroenterology
|
2007
|
0.75
|